AstraZeneca Pharma India Balance Sheet Health
Financial Health criteria checks 6/6
AstraZeneca Pharma India has a total shareholder equity of ₹6.8B and total debt of ₹0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ₹12.4B and ₹5.6B respectively. AstraZeneca Pharma India's EBIT is ₹1.4B making its interest coverage ratio -4.3. It has cash and short-term investments of ₹5.0B.
Key information
0%
Debt to equity ratio
₹0
Debt
| Interest coverage ratio | -4.3x |
| Cash | ₹4.97b |
| Equity | ₹6.79b |
| Total liabilities | ₹5.62b |
| Total assets | ₹12.41b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 506820's short term assets (₹10.7B) exceed its short term liabilities (₹4.7B).
Long Term Liabilities: 506820's short term assets (₹10.7B) exceed its long term liabilities (₹871.2M).
Debt to Equity History and Analysis
Debt Level: 506820 is debt free.
Reducing Debt: 506820 had no debt 5 years ago.
Debt Coverage: 506820 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 506820 has no debt, therefore coverage of interest payments is not a concern.